HLF Related Analyst Comments
-
Shorts Buried in MLM Companies (HLF) (USNA) (NUS)
-
Herbalife (HLF) Making the Right Moves - DA Davidson
-
UPDATE: DA Davidson Upgrades Herbalife (HLF) to Buy; Boosts PT Up to $78
-
Height Analytics Doesn't See Significant Sanctions on Large MLM Cos. in the Near-Term (HLF) (NUS) (USNA) (BTH)
-
Deutsche Bank Says Nu Skin (NUS) Attacks 'Unfounded and Misguided'
-
Strong Q4 Results, Boosted Outlook from Herbalife (HLF) Has Analysts Talking
-
Deustche Bank Talks Direct Selling Industry after Fortune Hi-Tech Marketing Takedown (AVP) (HLF) (NUS)
-
DA Davidson Boosts Target on Herbalife (HLF) to $78; Could Be Worth $180 Long Term
-
'Mother of all Short Squeezes' Could Punish Ackman and Other Herbalife (HLF) Shorts
-
Is Herbalife (HLF) About to Rock Ackman's World?
-
Herbalife (HLF) Becomes 'Best Idea for 2013' at One Firm Amid Ackman Bashing
-
B. Riley Drops Coverage of Herbalife (HLF) Amid Ack-Attack
-
Wedbush Says Weight Watchers (WTW) Should Trade a 10% Discount to Peers
-
Canaccord Genuity Positive on Herbalife (HLF) After Global Growth Conference; Attractive Valuation
-
Herbalife (HLF) Sees Volatility As SEC Questions Discussed
-
Canaccord Genuity reiterates a 'Buy' on Herbalife (HLF); Currency and China Concerns Dismissed
-
Auriga Maintains a 'Buy' on Herbalife (HLF); Spark From Additional Licenses in China
-
Canaccord Genuity Reiterates a 'Buy' on Herbalife (HLF); New China Licenses Reinforce Strong Growth Outlook
-
Auriga Reiterates a 'Buy' on Herbalife (HLF); Shares Still Offer Material Upside
-
Canaccord Genuity Reiterates Bullish Stance on Nu Skin (NUS)
-
Canaccord Genuity Said Relief Rally in Herbalife (HLF) Should Continue
-
Auriga Maintains 'Buy' on Herbalife (HLF); Takeaways From Analyst Meeting
-
Caris Downgrades Herbalife (HLF), Sees Einhorn Announcing Stock as Next Short
-
Herbalife (HLF) Shares Continue Lower Despite Numerous 'Buy the Weakness' Calls
-
DA Davidson Defends Herbalife (HLF); Short-Seller Questions Create Major Buying Opportunity
-
Auriga Maintains a 'Hold' on Herbalife (HLF); Beating Sustained Growth
-
Auriga Maintains a 'Hold' on Herbalife (HLF); Expect Improvement in 1Q
-
Canaccord Genuity Reiterates a 'Buy' on Herbalife (HLF); Model Should Continue Driving Double-digit Revenue & EPS Growth
-
Barclays Maintains an 'Overweight' on Herbalife (HLF); Increasingly Confident After Attending Investor Day
-
Auriga Reiterates a 'Hold' on Herbalife (HLF); Raising Numbers on Strong Q4
-
DA Davidson Raises Price Target on Herbalife (HLF) Following Strong Q4 Results
-
Canaccord Genuity on Consumer & Retail: Direct Selling Preview: Some Momentum, Some Currency and Some Questions - A Range-Bound Group in Q4
-
Canaccord Genuity Reiterates a 'Buy' on Herbalife (HLF); Business Momentum Continues, Adjusting Estimates for Currency
-
DA Davidson Raises Price Target on Herbalife (HLF) to $75 as Sales Rose 28% and EPS Rose 35%
-
Jefferies Comments on Herbalife's (NYSE: HLF) Strong Q2 Results
-
Canaccord Genuity on Consumer Products - Health, Wellness and Lifestyle: Direct Selling Q2 Preview - Growth Continues
-
DA Davidson Raises Price Target on Herbalife (HLF), New Price Target Calls for 20% Upside
-
Canaccord Genuity Reiterates a 'Buy' on Herbalife (HLF); China: Yet Another Quality Daily Consumption Opportunity
-
Wedbush Raises Price Target on Herbalife (HLF), Beat Q1 Expectations, Raised Dividend and Guidance
-
Canaccord Genuity Reiterates a 'Buy' on Herbalife (HLF); Outlook Remains Favorable for Strong Revenue and Earnings Growth
-
Canaccord Genuity Reiterates a 'Buy' on HLF; Can't Find an Achilles' Heel at Herbalife
-
Jefferies Raises Estimates & Price Target on Herbalife (HLF), Strong 2011 Guidance & 4Q10 Results
-
Canaccord Genuity Morning Coffee on Weight Watchers (WTW): Shrinking Waistlines = Growing Profit
-
Canaccord Genuity Reiterates a 'Buy' on Herbalife (HLF); Q4 Preview: Growth to Continue
-
Canaccord Genuity Reiterates a 'Buy' Rating on Herbalife (HLF); Trends Continue Into Analyst Day
-
Price Target on Herbalife (HLF) Lifted to $64 at Wedbush; Reiterates Outperform
-
Canaccord Adams Reiterates a 'Buy' on Herbalife (HLF); Biggest Markets Accelerating
-
Argus Maintains a 'Buy' Rating on Herbalife (HLF); Raises PT
-
Canaccord Adams Reiterates a 'Buy' on Herbalife (HLF); Plenty of Growth Drivers; Raises PT
-
Wedbush Raises Herbalife (HLF) Target to $45; Maintains Outperform
Back to HLF Stock Lookup
